C3 Improved outcomes: Better health
Monday 11 September 2017
14:30-17:30
COEX Convention & Exhibition Center : Grand Ballroom 103 3 hours
Organised by the FIP Community Pharmacy Section, the FIP Health and Medicines Information Section, the FIP Social and Administrative Pharmacy Section and the FIP Industrial Pharmacy Section
Chairs: Manjiri Gharat (Indian Pharmaceutical Association, India) and Parisa Aslani (The University of Sydney, Australia)
Introduction
Adherence means taking the correct dose of your medicines every time, exactly as prescribed by your health care provider or recommended by your pharmacist. Adherence can also be defined as “The extent to which a person’s behaviour — taking medicine, following a diet, or making healthy lifestyle changes — corresponds with agreed-upon recommendations from a health care provider” (World Health Organization, 2003)
Chronic conditions currently account for three of every four dollars spent on health care, a factor of their prevalence and the spiralling cost of specialty drugs to treat them. And the burden of chronic diseases is a global and growing problem. Since medicines play a significant role in the management of chronic diseases, with patients usually having to visit their community pharmacy regularly to collect their medicines, pharmacists are ideally positioned to provide additional chronic disease management services.
Because barriers to medication adherence are complex and varied, solutions to improve adherence must be multifactorial. Improving adherence is crucial to the future sustainability of our health systems, where community and hospital pharmacy have vital roles to play. The cost of non-adherence can be calculated both in terms of generating additional costs for health care systems due to misuse or non-use of medicines leading to further treatment or even hospitalisation, and by simply wasting resources through the non-use of prescribed medicines funded by health care systems.
Suboptimal health literacy and lack of involvement in the treatment decision-making process will also affect adherence and outcome of the therapy.
Learning objectives
At the conclusion of this knowledge-based session, participants will be able to:
- Identify effective targeted interventions to address the barriers to adherence.
- Describe the range of chronic conditions where pharmacists can play a significant role in supporting adherence to therapy.
- Identify non-adherence through the use of medication management systems, and deliver targeted interventions for a range of chronic conditions.
- Identify the lack of health literacy as a risk factor in adherence.
Programme
14:30 – 14:35
1. Introduction by the chair
14:35 – 15:00
2. What patients need
Ki-Jong Ahn (Korean Alliance of Patient Organizations, Republic of Korea)
15:00 – 15:25
3. Adherence and medicines management for chronic diseases
Victoria Garcia Cardenas (University of Technology Sydney, Australia)
15:25 – 15:50
4. The value of health literacy among patients for improved adherence
Parisa Aslani (The University of Sydney, Australia)
15:50 – 16:10 Coffee/tea break
16:10 – 16:35
5. Adherence 3.0 (innovative approaches to increase adherence and outcomes)
John Shaske (Ascent Health Care Consultants, Canada)
16:35 – 17:00
6. Specific examples of how the pharmaceutical industry co-operates with pharmacy in optimising therapy and outcomes
Ulf Janzon (Merck Sharp & Dohme, Sweden)
17:00 – 17:30
7. Discussion and take home messages
